RHEUMAJECTA IN THE TREATMENT OF RHEUMATOID ARTHRITIS

SUMMARY A double-blind controlled trial of Rheumajecta in rheumatoid arthritis demonstrated lack of effect of this compound and unacceptable side-effects. It was not felt ethically justifiable to complete the trial.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology (Oxford, England) England), 1980-02, Vol.19 (1), p.60-61
Hauptverfasser:	BIRD, H. A., RHIND, V. M., WRIGHT, V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Catalase - therapeutic use Choline O-Acetyltransferase - therapeutic use Drug Combinations - therapeutic use Drug Evaluation Humans Nucleotidyltransferases - therapeutic use Sulfate Adenylyltransferase - therapeutic use Sulfurtransferases - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	SUMMARY A double-blind controlled trial of Rheumajecta in rheumatoid arthritis demonstrated lack of effect of this compound and unacceptable side-effects. It was not felt ethically justifiable to complete the trial.
ISSN:	1462-0324 0300-3396 1462-0332
DOI:	10.1093/rheumatology/19.1.60